Indazole compounds and methods of use thereof

Aryl-substituted benzimidazole and imidazopyridine ethers

Pyrimidine derivatives as modulators of chemokine receptor activity

Nitrogen-containing aromatic derivatives

Tetrazole compounds and their use as metabotropic glutamate receptor antagonists

Quinazoline derivatives as angiogenesis inhibitors

Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors

Process for manufacturing a micro-fluid ejection device

3-amino-2-phenylpyrrolidine derivatives

Certain triazole-based compounds, compositions, and uses thereof

Quinazoline derivatives as kinase inhibitors

Anti-inflammatory medicaments

Compounds as inhibitors of hepatitis C virus NS3 serine protease

Non nucleoside reverse transcriptase inhibitors

Indole derivatives as H3 inverse agonists

Cannabinoid receptor ligands

Processes for preparing gonadotropin releasing hormone receptor antagonists

Vasculostatic agents and methods of use thereof

Oxindole derivatives

Heteroaryl-hydrazone compounds

Five-membered heterocycles useful as serine protease inhibitors

CIS-imidazolines

Indoles having anti-diabetic activity

4,5-disubstituted-2-aryl pyrimidines

Pyridine derivative and pyrimidine derivative

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

Vanilloid receptor ligands and their use in treatments

Pyrimidine kinase inhibitors

Pyrimidine derivatives for treatment of hyperproliferative disorders

Vanilloid receptor ligands and their use in treatments

Vanilloid receptor ligands and their use in treatments

Phosphodiesterase 4 inhibitors

NK1 antagonists

Benzimidazoles, process for their preparation and use thereof as medicament

Vanilloid receptor ligands and their use in treatments

Diaminopyrimidinecarboxamide derivative

4-substituted piperidine derivatives

Hydrazonopyrazole derivatives and their use as therapeutics

Ribosome structure and protein synthesis inhibitors

3-aminocarbonyl substituted benzoylpyrazolones

Vanilloid receptor ligands and their use in treatments

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Benzimidazole and imidazopyridine derivatives and use thereof as a medicament

3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors

Ansamycins having improved pharmacological and biological properties

Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

Propane-1, 3-dione derivative

Modulators of cellular adhesion

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands

Inhibitors of hepatitis C virus NS3 protease

Pyrrolidine and thiazolidine compounds

Tyrosine kinase inhibitors

Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4

Inhibitors of human phosphatidylinositol 3-kinase delta

Piperizinones as modulators of chemokine receptor activity

Imidazole compounds

Indole, azaindole and related heterocyclic N-substituted piperazine derivatives

Pyrimidines as PLK inhibitors

Substituted heteroaryl derivatives, compositions, and methods of use

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Tetracyclic lactam derivatives and uses thereof

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

Dipeptidyl peptidase inhibitors

Aminotriazole compounds useful as inhibitors of protein kinases

Compositions and methods relating to novel compounds and targets thereof

Substituted pyrazolyl compounds for the treatment of inflammation

Preparation and use of imidazole derivatives for treatment of obesity

β-alanine derivatives and the use thereof

Pyrimidine derivatives for the treatment of abnormal cell growth

Pyrimidine derivatives for the treatment of abnormal cell growth

Substituted piperazines

Pyrimidine derivatives for the treatment of abnormal cell growth

Compounds, their use and preparation

Protease inhibitors

Scalable synthesis of imidazole derivatives

Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

Pyrimidine compounds

Quinazolinyl compounds as inhibitors of potassium channel function

Fused heterocyclic compounds

4-phenylamino-quinazolin-6-yl-amides

Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss

2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12

Tri-substituted ureas as cytokine inhibitors

Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1

Benzotriazine inhibitors of kinases

Inhibitors of histone deacetylase

Pyrazole derivatives as herbicidal compositions containing them

1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma

New compounds

Substituted hydroxyethylamine aspartyl protease inhibitors

Tri-substituted ureas as cytokine inhibitors

Novel compounds

Substituted hydroxyethylamine aspartyl protease inhibitors

Quinazoline derivatives and pharmaceutical compositions containing them

N-heterocyclic inhibitors of TNF-α expression

Process for preparing 3-aryloxy-phenylacetic acid compounds

Aryl-containing 5-acylindolinones, the preparation thereof and their use as medicaments

Triazoles as farnesyl transferase inhibitors

Use of 1H-indol-3-yl-2-oxoacetamide compounds

Diamino-pyrimidines and their use as angiogenesis inhibitors

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Capped pyrazinoylguanidine sodium channel blockers

Dipeptidyl peptidase-IV inhibitors

Quinoxalines useful as inhibitors of protein kinases

Pyrazole derivative

Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds

Organic compounds

Substituted 1-benzazepines and derivatives thereof

Amino-substituted tricyclic derivatives and methods of use

Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders

Capped pyrazinoylguanidine sodium channel blockers

3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors

Tetrahydro-indazole cannabinoid modulators

Bicyclic heterocycles useful as serine protease inhibitors

Vanilloid receptor ligands and their use in treatments

Crystalline polymorph of bazedoxifene acetate

Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity

Fluorescent dyes (AIDA) for solid phase and solution phase screening

N-sulfonyldicarboximide containing tethering compounds

Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase

Inhibitors of GSK-3 and uses thereof

Viral polymerase inhibitors

Pyrrolidine compounds

Nitrogen heterocycle biaryls for osteoporosis and other diseases

Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient

Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives

Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Benzenesulfonamide derivatives as antipsychotic agents

Azetidine derivatives as CCR-3 receptor antagonists

Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them

Fluorene-based compound and organic electroluminescent display device using the same

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

Substituted indoles and their use as hcv inhibitors

Imidazole compounds for the treatment of neurodegenerative disorders

Pyrrolidine-3,4-dicarboxamide derivatives

Tetrahydrocarbazoles and derivatives

4-anilino quinazoline derivatives as antiproliferative agents

Inhibitors of glutaminyl cyclase

Melanin concentrating hormone receptor antagonist

Method for preparing cyclic compounds

Benzimidazoles useful as modulators of ion channels

Diaminopyrimidines as P2Xand P2Xantagonists

Fused cyclic systems useful as inhibitors of TEC family protein kinases

Aryl oximes

Pyridazinone ureas as antagonists of alpha4 integrins

Compositions and methods for inducing cardiomyogenesis

5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them

Antibiotic compounds

Indolinone derivatives

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Indolyl derivatives

Ion channel modulators

2-(Phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses

Kinase inhibitors

Cycloalkyl—containing 5-acylindolinones, the preparation thereof and their use as medicaments

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

N-substituted prodrugs of fluorooxindoles

Carboxylic acid amides, the preparation thereof and their use as medicaments

Substituted fused bicyclic amines as modulators of chemokine receptor activity

Amide compounds as ion channel ligands and uses thereof

Indole derivatives or benzimidazole derivatives for modulating IκB kinase

Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof

Indazole derivatives as inhibitors of hormone sensitive lipase

Substituted spiro azabicyclics as modulators of chemokine receptor activity

Rho-kinase inhibitors

3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors

Quinazolinone compounds with reduced bioaccumulation

Heteroarylaminopyrazole derivatives useful for the treatment of diabetes

Amide compounds as ion channel ligands and uses thereof

Pyrrolidone carboxamides

Ligands of melanocortin receptors and compositions and methods related thereto

Pyridazinones as antagonists of alpha4 integrins

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Integrin receptor inhibitors

Triazoles as oxytocin antagonists

Nitrogen-containing aromatic derivatives

Compositions useful as inhibitors of voltage-gated ion channels

Herbicides

Vanilloid receptor ligands and their use in treatments

Phthalimide compounds useful as protein kinase inhibitors

Fused ring 4-oxopyrimidine derivative

Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them

Process for the preparation of pyrimidine derivative, intermediate therefor and process for the preparation thereof

Method of preparing maleimide functionalized polymers

Pyrrole substituted 2-indolinone protein kinase inhibitors

2-cyano-4-fluoropyrrolidine derivative or its salt

N-'4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases

7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders

Chk-1 inhibitors

Vanilloid receptor ligands and their use in treatments

Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Amide derivatives as glycogen synthase kinase 3-β inhibitors

Integrin expression inhibitor

Selective NPY (Y5) antagonists

Sulfonylamino-derivatives as novel inhibitors of histone deacetylase

Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation

2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

Indole-type inhibitors of p38 kinase

Histamine-3 receptor modulators

3-Azabicyclo[3.1.0]hexane derivatives

Prodrugs of potassium channel inhibitors

Carboxylic acid amides

4,5-Disubstituted-2-aminopyrimidines

Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists

Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists

Methods and compositions as protein kinase inhibitors

Benzamide derivatives useful as histone deacetylase inhibitors

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

Amine compounds and use thereof

Substituted indoles

Retinoic acid mimetic anilides

Piperazinyl-, piperidinyl- and morpholinyl-derivatives as inhibitors of histone deacetylase

Benzimidazoles and analogs thereof as antivirals

N-substituted benzene sulfonamides

N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient

Herbicides

2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses

3-substituted oxindole β3 agonists

5-Aryltetrazole compounds and uses thereof

Substituted bicyclic derivatives for the treatment of abnormal cell growth

Ethylene diamine derivatives and their use as orexin-receptor antagonists

5-Aryltetrazoles compounds and compositions thereof

N-alkyl pyrroles as HMG-CoA reductase inhibitors

Nitrogen-containing heteroaryl derivatives

5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine

1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders

Methods to modulate conditions mediated by the CXCR4 receptor

Vanilloid receptor ligands and their use in treatments

Substituted indoles

Triazole compounds

N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity

Inhibitors of hepatitis C virus NS3/NS4a serine protease

Conjugated small molecules

Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof

Heterocyclic ketone and thioester compounds and uses

Carbonylamino-derivatives as novel inhibitors of histone deacetylase

Indinavir derivatives useful in immunoassay

Quinoxalinones

Imidazole compositions useful as inhibitors of protein kinases

Insecticidal amides with nitrogen-containing benzo-Fused bicyclic ring systems

N3 alkylated benzimidazole derivatives as MEK inhibitors

Inhibitors of interleukin-1beta converting enzyme

Pharmaceutical compounds

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof

hPPARs activators

Medical devices employing triazine compounds and compositions thereof

Compositions useful as inhibitors of voltage-gated sodium channels

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Optical interleaver

Azole derivatives as antifungal agents

Amide compounds and medications containing the same

Amide compounds and medications containing the same technical field

N-arylheteroaromatic products compositions containing them and use thereof

Inhibitors of akt activity

Inhibitors of p38 kinase

AKT protein kinase inhibitors

Immobilized N-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets

Ecstasy haptens and immunogens

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

Indole compounds

Benzylcycloalkyl amines as modulators of chemokine receptor activity

Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

Pyrimidine derivatives useful as inhibitors of PKC-theta

Pharmaceutical compounds

Medical devices employing triazine compounds and compositions thereof

5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists

Benzo-fused heterocycles as endothelin antagonists

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor

Mitotic kinesin inhibitors

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

Pyrimidine Aselective antagonist compounds, their synthesis and use

Phenylpyrimidine amines as ige inhibitors

Amino-derivatives as novel inhibitors of histone deacetylase

Cyclic amine BACE-1 inhibitors having a benzamide substituent

Macrocyclic inhibitors of hepatitis C virus NS3-serine protease

Antibacterial agents

2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

Sulfonyl-Derivatives as novel inhibitors of histone deacetylase

Therapeutic substituted indazole derivatives

Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them

Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases

Medical devices employing triazine compounds and compositions thereof

Electrophotographic organophotoreceptors with novel charge transport compounds

Alpha-ketoamide derivatives as cathepsin k inhibitors

Process for producing optically active sulfoxide derivative

Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith

Pyrimidine-2,4,6-trione metalloproteinase inhibitors

Alpha-ketoamides and derivatives thereof

Inhibitors of histone deacetylase

Pyrrole derivatives as antimycobacterial compounds

Inhibitors of cathepsin S